Factory Floor or Microbe Vat? Picking the Perfect Platform for Biologics
The biopharmaceutical industry thrives on biologics – complex molecules used in drugs and therapies. But how do we produce them? Two main options dominate: fermentation and cell culture. Each boasts unique strengths and weaknesses, making the choice crucial.
Fermentation, a well-established technique, leverages microbes like bacteria and yeast. It's a champion of speed and scalability, churning out large quantities of simpler biologics efficiently. Plus, it's often less expensive. However, complexity has its limitations. Fermentation struggles with intricate molecules requiring specific modifications, like some proteins.
Cell culture, on the other hand, excels in complexity. Mammalian cells, similar to our own, can perform intricate modifications essential for certain biologics. This makes them ideal for producing advanced drugs like monoclonal antibodies. But here's the catch: cell culture is slower, more demanding, and often costlier.
So, which method reigns supreme? The answer lies in the biologic itself. For simpler molecules, fermentation's efficiency shines. But for intricate structures, cell culture's precision takes center stage. The future holds promise for advancements, like engineered microbes capable of more complex tasks. Ultimately, the choice boils down to finding the perfect match between the biologic and the production platform, ensuring a successful journey from the lab to the patient.
Visit our website to know more: https://www.leadventgrp.com/events/2nd-annual-bioprocessing-and-biologics-forum/details
For more information and group participation, contact us: [email protected]
Leadvent Group - Industry Leading Events for Business Leaders!
www.leadventgrp.com| [email protected]
